Utilization of Eucalyptus (Eucalyptus Spp.) Plant in Value-Added Cosmetic, Health and Food Products: Biological Activities, Industrial Potential and Economic Importance

Abstract

The present research aimed to characterize the phenolic composition of eucalyptus (Eucalyptus spp.) leaf extract and to investigate the possible industrial applications of these bioactive constituents. Phenolic compounds were identified and quantified through high-performance liquid chromatography coupled with a diode-array detector (HPLC-DAD). Analytical findings demonstrated the presence of nearly twenty distinct phenolic substances within the extract. Among the detected compounds, alizarin exhibited the highest concentration (265.72 ng/µL), followed by gallic acid (86.73 ng/µL). Several additional phytochemicals, including ascorbic acid, hydroxybenzoic acid, rutin, naringin, hesperidin, resveratrol, and quercetin, were also detected at varying levels. The diverse phenolic profile obtained from eucalyptus leaves suggests a substantial reservoir of biologically active molecules with notable functional properties. Many of these compounds are recognized for their capacity to neutralize reactive oxygen species, suppress microbial growth, and modulate inflammatory processes. Consequently, eucalyptus-derived extracts may represent promising natural ingredients for incorporation into pharmaceutical preparations, cosmetic products, and health-related formulations. Moreover, their potential role as naturally derived preservatives and oxidation inhibitors may support the development of cleaner-label food products and reduce dependence on synthetic additives. Overall, the findings highlight eucalyptus leaves as a valuable source of phenolic constituents with broad applicability in natural product research. The observed phytochemical richness further supports the utilization of eucalyptus biomass in environmentally friendly production systems, sustainable biotechnology, and green chemistry-based innovation strategies aimed at developing high-value bioactive products.